A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancerAnjali Bisht, Balak Das Kurmi, Preeti Patel et al.|Drug Delivery and Translational Research|2024Cited by 141
Aptamer as a targeted approach towards treatment of breast cancerAnjali Bisht, Balak Das Kurmi, Shuvadip Bhowmik et al.|Journal of drug targeting|2024Cited by 7
Empowering Antimicrobial Peptides: Harnessing Nanotechnology and Engineering Strategies to Combat Microbial ResistanceDubey Avinash, Balak Das Kurmi, Anjali Bisht et al.|Peptide Science|2024Cited by 2